Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Yoshida

Showing results (301-310 of 316) with videos related to

Pageof 32
Sort By:
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
The Journal of Dermatology|February 14, 2023
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective studyTetsuji Yanase, Noriko Tsuruta, Kazuki Yamaguchi, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
Pageof 32

Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|April 23, 2024
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in JapanTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Clinical and Molecular Hepatology|January 24, 2024
Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE studyMichihiro Iwaki, Hideki Fujii, Hideki Hayashi, et al.
The Journal of Dermatology|February 14, 2023
Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective studyTetsuji Yanase, Noriko Tsuruta, Kazuki Yamaguchi, et al.
Journal of Gastroenterology and Hepatology|February 17, 2023
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia studyHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Gastro Hep Advances|August 12, 2024
Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLDHidenori Toyoda, Hideki Fujii, Michihiro Iwaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 20, 2022
Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort StudyHideki Fujii, Michihiro Iwaki, Hideki Hayashi, et al.
Gastro Hep Advances|June 11, 2025
Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7SHiroshi Ishiba, Yoshio Sumida, Yoshihiro Kamada, et al.
Journal of Gastroenterology|December 5, 2022
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT ForumYoshihiro Kamada, Takahiro Nakamura, Satoko Isobe, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
Pageof 32